| Research and Markets: Essential Chartbook of International ... |
MarketWatch - 2 hours ago
... Industry Companies Mentioned: - Abbott Laboratories - Actelion - Amgen - Astellas Pharma - AstraZeneca - Bayer AG - Biogen Idec - Boehringer Ingelheim ...
|
| Big Pharma M&A Analysis to 2012 |
Pharmaceutical Business Review - 14 hours ago
Despite this, there is a definite grouping of four companies (Gilead, Genzyme, Biogen Idec and Cephalon) that offer universal uplift benefits to potential ...
|
| Too Much Punishment for Amylin |
Motley Fool - 21 hours ago
A few weeks ago, Elan (NYSE: ELN) and Biogen Idec (Nasdaq: BIIB) had to deal with new cases of a brain disorder in patients using their multiple sclerosis ...
|
| Cascade Controls Changes Corporate Identity to Cascade Solutions |
eMediaWorld.com Newswire Press Release Distribution Service (press release), AZ - 22 hours ago
Their life science customers have included Abbott Laboratories, Amgen, Biogen Idec, Genentech, and Pfizer. Chemical processing customers include DSM, ...
|
| National Geographic and NewsGator Partner to Create Viral Widget ... |
Earthtimes (press release), UK - Aug 19, 2008
... of the world's most recognized brands, including Bank of America, Biogen Idec, CBS, CNN, Discovery, National Geographic, Procter & Gamble and USA Today. ...
|
| Tysabri Forecast to Achieve Blockbuster Status by 2014 |
PharmiWeb.com (press release), UK - Aug 19, 2008
On July 31, 2008, Biogen Idec and Elan filed a current report with the Securities and Exchange Commission which was the first public disclosure of the two ...
|
| Cell Therapeutics running out of cash |
Seattle Times, United States - Aug 19, 2008
It is counting on expanding the market for Zevalin, a radio-immunotherapy drug it recently bought from Biogen Idec, to increase its sales revenue from $2.9 ...
|
